Equity Overview
Price & Market Data
Price: $0.0₃7
Daily Change: +$0.0₃1 / 14.29%
Range: $0.0₃6 - $0.0304
Market Cap: $522,392
Volume: 50,000
Performance Metrics
1 Week: 4.00%
1 Month: -42.22%
3 Months: 420.0%
6 Months: -96.77%
1 Year: -97.34%
YTD: -94.84%
Details
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.